Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels.
作者： Misako Ohmiya , Jun Hayashi , Kumiko Ueno , Norihiro Furusyo , Yasunori Sawayama
关键词:
摘要: To determine the effects of interferon treatment, we studied 77 Japanese patients with hepatitis C virus (HCV) infection and normal alanine aminotransferase (ALT). Of patients, 37 were given natural interferon-alpha for 24 weeks, 40 not acted as controls. Serum samples tested HCV RNA genotypes by polymerase chain reaction (PCR). levels measured competitive PCR. treated 11 (29.7%) had sustained elimination throughout a six-month follow-up, while was eliminated in any untreated patients. At months, number elevated ALT significantly different between (13.5%) (15%). Interferon eliminates without severe side effects. The history should be clarified so that treatment regimen can tailored to needs each patient.
springer.com
elsevier.com
cabdirect.org
sci-hub.se 参考文章(30)
Hideki Hagiwara, Norio Hayashi, Eiji Mita, Tetsuo Takehara, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada, Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy Gastroenterology. ,vol. 104, pp. 877- 883 ,(1993) , 10.1016/0016-5085(93)91025-D
W. P. Dixon, BMPD statistical software manual Berkeley: University of California Press. ,(1988)
Norihiro Furusyo, Jun Hayashi, Kumiko Ueno, Yasunori Sawayama, Yasunobu Kawakami, Yasuhiro Kishihara, Seizaburo Kashiwagi, Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosis Clinical Therapeutics. ,vol. 19, pp. 1352- 1367 ,(1997) , 10.1016/S0149-2918(97)80010-0
A. Alberti, G. Morsica, L. Chemello, D. Cavalletto, F. Noventa, P. Pontisso, A. Ruol, Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV The Lancet. ,vol. 340, pp. 697- 698 ,(1992) , 10.1016/0140-6736(92)92234-7
Q. Choo, G Kuo, A. Weiner, L. Overby, D. Bradley, M Houghton, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science. ,vol. 244, pp. 359- 362 ,(1989) , 10.1126/SCIENCE.2523562
Naoya Kato, Osamu Yokosuka, Kazuhiko Hosoda, Yoshimi Ito, Masao Ohto, Masao Omata, Quantification of hepatitis C virus by competitive reverse transcription—polymerase chain reaction: Increase of the virus in advanced liver disease Hepatology. ,vol. 18, pp. 16- 20 ,(1993) , 10.1002/HEP.1840180104
Koichi Kanai, Koichiro Iwata, Kuniaki Nakao, Makoto Kako, Hiroaki Okamoto, Suppression of hepatitis C virus RNA by interferon-α The Lancet. ,vol. 336, pp. 245- ,(1990) , 10.1016/0140-6736(90)91768-6
Jun Hayashi, Koya Nakashima, Eriko Yoshimura, Miki Hirata, Yoshiaki Maeda, Seizaburo Kashiwagi, Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan Journal of Gastroenterology. ,vol. 29, pp. 147- 151 ,(1994) , 10.1007/BF02358675
Kendo Kiyosawa, Eiji Tanaka, Takeshi Sodeyama, Kiyoshi Furuta, Seiichi Usuda, Muhammad Yousuf, Seiichi Furuta, Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma. Japanese Journal of Cancer Research. ,vol. 81, pp. 1089- 1091 ,(1990) , 10.1111/J.1349-7006.1990.TB02517.X
Jun Hayashi, Koya Nakashima, Eriko Yoshimura, Yasuhiro Kishihara, Misako Ohmiya, Miki Hirata, Seizaburo Kashiwagi, Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan Journal of Infection. ,vol. 28, pp. 271- 277 ,(1994) , 10.1016/S0163-4453(94)91743-4